Here are relevant reports on : cell-therapy-market
-
Cell Counting Market by Product (Instruments (Spectrophotometer, Flow Cytometer, Hematology Analyzers, Cell Counters), Consumables (Media, Reagents, Assays, Microplate)), Application, End User (Pharma & Biotech) - Global Forecast to 2029
The global Cell Counting Market, valued at US$10.82 billion in 2023, grew to US$11.12 billion in 2024 and is projected to reach US$11.83 billion in 2025. The market is expected to advance at a robust CAGR of 7.7% from 2024 to 2029, reaching an estimated US$16.14 billion by 2029. Increasing awareness and adoption of automated and fluorescence-based cell counters, along with declining costs, are driving broader market penetration across research laboratories, clinical diagnostics, and biopharmaceutical applications.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Cell Analysis Market by Product & Service (Consumables, Instruments), Technique (Flow Cytometry, PCR, Microscopy), Process (Counting, Viability, Proliferation, Interaction, Single-cell Analysis), End User (Pharma, Biotech) - Global Forecast to 2028
The global cell analysis market, valued at US$18.6 billion in 2022, stood at US$20.2 billion in 2023 and is projected to advance at a resilient CAGR of 10.9% from 2023 to 2028, culminating in a forecasted valuation of US$33.9 billion by the end of the period. Increase in the preference for cell-bsaed assays along with strong funding for cell-based research is expected to drive the market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030)
The global single-cell analysis market, valued at US$3.55 billion in 2024, stood at US$3.81 billion in 2025 and is projected to advance at a resilient CAGR of 14.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.56 billion by the end of the period.Growth in this market can be attributed to factors such as the rising incidence of cancer and immunological disorders, technological developments in single-cell analysis products, the growing focus on the advancement of stem cell research, and the increasing focus on the biotechnology sector.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Cell Lysis Market / Fractionation Market by Product (Consumables (Enzymes, Detergent), Instruments (Sonicators)), Cell Type (Mammalian), Application (Protein Purification), End User (Biopharmaceutical & Biotechnology Companies) & Region - Global Forecast to 2026
The global cell lysis market growth is primed to transition from $2.9 billion in 2021 to $4.1 billion by 2026, showcasing a strong CAGR of 7.2%. Growth of the market is driven mainly by increasing government funding for research, the high prevalence of diseases, and a growing focus on personalised medicine.
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
Hydrogen Fuel Cell Catalyst Market - Global Forecast to 2030
The hydrogen fuel cell catalyst market is anticipated to grow from USD 0.53 billion in 2024 to USD 1.37 billion by 2030 with a CAGR of 17.1% during 2025–2030. The Hydrogen Fuel Cell Catalyst Market refers to the global industry involved in the development, production, and sale of catalysts used in hydrogen fuel cells. These catalysts are critical components that facilitate the electrochemical reactions within the fuel cells, enabling the conversion of hydrogen and oxygen into electricity, with water and heat as byproducts.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Solar Cell Market by Type, End-Use Industry, Application and Region – Global Forecast to 2030
The solar cell market outlook is positive and promising. Solar cells, also known as photovoltaic (PV) cells, are devices that convert sunlight into electricity. They play a crucial role in the generation of clean and renewable energy.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Hot Cell Market - By Type, Application & Geography - 2018
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Nanotechnology based Portable & Stationary Fuel Cell Market, Global Forecast & Analysis (2011 - 2016)
Nanotechnology have great potential in materials, component and fuel cell/stack producers. The technology could improve material properties, the functionality and performance of components, and decrease price. The heavy price of fuel cells and a lack of infrastructure have been the biggest barriers to commercialization and thus nanotechnology can become a kind of catalyst for speeding up the commercialization of fuel cell applications.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Renal Cancer Drugs Market by therapy (targeted therapy, chemotherapy, and immunotherapy), drug class (anti-angiogenesis, mTOR inhibitors, interleukin, and immune checkpoint inhibitors), indication (renal cell carcinoma, urothelial carcinoma, and others), distribution channel (hospitals, specialty & retail pharmacies and others), and region (North America, Europe, Asia Pacific and Rest of the World (RoW) which includes Latin America and Middle East & Africa) – global forecasts to 2027
The renal cancer drugs market is projected to reach USD 8 billion by 2027 from USD 6 billion in 2022, at a CAGR of 6% during the forecast period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Digital Therapeutics Market / DTx Market by Offerings (Platform, Virtual Reality/Games), Revenue Model (Subscription, Value Based), Application (Therapy (Diabetes, Obesity, CNS, Respiratory, CVD), Drug Adherence, Rehab/Patient care) - Global Forecast to 2028
The global digital therapeutics market, valued at US$4.4 billion in 2022, stood at US$6.1 billion in 2023 and is projected to advance at a resilient CAGR of 29.1% from 2023 to 2028, culminating in a forecasted valuation of US$21.9 billion by the end of the period. The rapid adoption of digital therapeutics is driven by the rising incidence of chronic diseases, surging investments from venture capital firms, and strategic partnerships between tech companies and healthcare providers.
- Published: January 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
